Inácio Ricardo Alves Vasconcelos

Inácio Ricardo Alves Vasconcelos

Auto-generated profile, based on publicly available information

Inácio Ricardo Alves Vasconcelos

Federal University of Paraíba

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2018 in Acta Brasiliensis
Verified
Journal Article
Open access
PDF file
MPMarcela Lins Cavalcanti de Pontes
Marcela Lins Cavalcanti de Pontes
IVInácio Ricardo Alves Vasconcelos
Inácio Ricardo Alves Vasconcelos
Margareth DinizMargareth Diniz
Margareth Diniz
HPHILZETH PESSÔA
HILZETH PESSÔA
Among the natural products, Brazilian propolis stands out because it is considered a source for the discovery of new bioactive compounds. In the last decade, a new Brazilian propolis has been described, known as red propolis due to its reddish pigment. Since then, numerous studies revealing its major components and their pharmacological activity have been described. Thes, this research had the objective of performing an integrative review of the literature on the biological activity of Brazilian red propolis. Scientific studies in the PubMed, SciElo and LILACS database were reviewed and analyzed using an inductive approach and indirect documentation technique. A total 418 publications were found, and onclusion and exclusion criteria were subsequently applied, selecting a total of 18 articles. The Brazilian propolis presents numerous pharmacological properties, especially the antibacterial, antfugal, antoxidant and anti-inflammatory effects. In addition, the chemical composition of this substance is different from other types of propolis already reported in the literature, presenting flavonoids never before reported. In this way, its chemical characteristics suggest probable therapeutic use for the human organism.

14 November 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
HNHumberto de Carvalho Aragão Neto
Humberto de Carvalho Aragão Neto
CCCamila Medeiros Costa
Camila Medeiros Costa
JPJoão Carlos Lima Rodrigues Pita
João Carlos Lima Rodrigues Pita
RCRicardo Castro
Ricardo Castro
IVInácio Ricardo Alves Vasconcelos
Inácio Ricardo Alves Vasconcelos
RBRubens Batista Benedito
Rubens Batista Benedito
The new coronavirus, SARS-CoV-2, which causes COVID-19 is easily transmitted from person to person. About 15% develop severe pneumonia and of these, 6% progress to severe acute respiratory syndrome (SARS) and multiple organ failure. Identify biomarkers that can predict which individuals are likely to be affected by severe disease and are at risk of death is crucial. However, the pathophysiology of the disease is not completely elucidated and the characterization of the clinical profile of people infected with SARS-CoV-2 remains unclear. Therefore, the objective of this study was to evaluate the epidemiological and laboratory profile of patients confirmed with COVID-19 and admitted to the University Hospital Lauro Wanderley, based on the correlation of laboratory tests to the evolution of the disease, determination of the most influential variables in the worsening of the disease. Data consisted of complete blood count and serum biochemical analyzes. Overall, 74 patients met all criteria of this study and were included, 40 from the Intensive Care Unit (ICU), and 34 from the Infectious Diseases Infirmary (IDP), both exclusively for patients with COVID-19. Based on these findings, patients with increased WBC count, ALT, AST, and LDH should be closely monitored as these factors predict ICU admission and mortality. Among other laboratory parameters, patients admitted to the ICU have higher levels of D-dimer compared to IDI patients. The results suggests that higher levels of D-dimer on admission is related to a worse prognosis of the disease.